But over the course of 2024, X, as it is now called, has evolved from what felt like a communal town square into a polarised hub where views and posts seem even more controversial.

Dec 23 (Reuters) - The U.S. Food and Drug Administration has revoked the emergency use authorization for four COVID-19 antibody-based drugs, including those from Eli Lilly (LLY.N), opens new tab ...

X (Twitter) has announced a big jump in pricing for its Premium Plus subscription tier, with monthly rates in the US jumping from $16 to $22, representing a 37.5% increase. The annual subscription ...

X has substantially raised the price of its top-tier user subscription in multiple regions to help bolster the platform’s creator payouts. The increase for Premium Plus came into effect on ...

X is raising prices for its top-tier subscription service, Premium+, by 37.5% to $22 a month, marking the largest price increase since Elon Musk bought the platform in 2022. The price hike will ...

A multi-center clinical trial (NISCI trial: Nogo-A Inhibition in acute Spinal Cord Injury Study) investigated the antibody NG 101 (anti-Nogo-A), which blocks and thus neutralizes the body's own ...

Additionally, the antibody proved “consistent across subgroups” and appeared well tolerated in both IBD conditions with no safety signals identified, according to the partners. Overall rates ...

Scientists in New Zealand blame waning antibody levels. Antibody responses in 150 regular blood donors were measured across the pandemic’s first three years for immunity against a range of ...

Users on X, which Musk has branded the "everything app," have been fleeing the platform. The ripple effects of the election season and Musk's support of Donald Trump have given a rise to a deluge ...